A Retrospective Comparative Study of Mid-Term Outcomes of Atherectomy, Drug-Coating Balloon Angioplasty, and Plain Old Balloon Angioplasty for Isolated Atherosclerotic Popliteal Artery Lesions.
amputation‐free
atherectomy
drug‐coating balloon
endovascular
patency rate
popliteal artery
Journal
Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554
Informations de publication
Date de publication:
28 Sep 2024
28 Sep 2024
Historique:
revised:
05
09
2024
received:
24
06
2024
accepted:
07
09
2024
medline:
28
9
2024
pubmed:
28
9
2024
entrez:
28
9
2024
Statut:
aheadofprint
Résumé
We retrospectively reviewed the clinical data of 217 consecutive Chinese patients with isolated atherosclerotic popliteal artery lesions treated with atherectomy technique, DCB, and plain old balloon angioplasty from August 2017 to August 2022. There was no difference in the 48-month patency rate between the atherectomy, DCB, and POBA groups (65%, 56%, and 51%, respectively; p = 0.3), as well as in adjusted Cox regression. Similarly, no difference was observed in the 48-month clinically driven target lesion revascularization-free (CDTLR-free) rate among the groups (77%, 74%, and 65%; p = 0.34), confirmed by adjusted Cox regression. In the 48 months, a significant difference was observed in amputation-free rates between the atherectomy, DCB, and POBA groups (97%, 91%, and 83%, respectively; p < 0.05). Adjusted Cox regression indicated POBA had worse outcomes than DCB and atherectomy. In the stenosis and occlusion subgroup, the 48-month primary patency rates were 65%, 70%, and 54% (p > 0.9) and 65% versus 49% versus 49% (p = 0.3), showing no differences among the three groups. In the short lesion subgroup (<10 cm), the 48-month primary patency rates were 65%, 66%, and 61% for atherectomy, DCB, and POBA, respectively (p = 0.7). In the long lesion subgroup (≥10 cm), the 48-month patency rates were higher in the atherectomy and DCB groups compared to POBA (64%, 44%, and 34%), with no significant difference among the groups (p = 0.13). DCB and atherectomy demonstrate improved short- and mid-term clinical outcomes compared to POBA in Chinese patients with popliteal artery disease.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). The Journal of Clinical Hypertension published by Wiley Periodicals LLC.
Références
A. Rastan, H. Krankenberg, I. Baumgartner, et al., “Stent Placement versus Balloon Angioplasty for the Treatment of Obstructive Lesions of the Popliteal Artery: A Prospective, Multicenter, Randomized Trial,” Circulation 127, no. 25 (2013): 2535–2541.
M. H. Shishehbor and M. R. Jaff, “Percutaneous Therapies for Peripheral Artery Disease,” Circulation 134, no. 24 (2016): 2008–2027.
R. E. Khoury, M. Brodmann, and P. A. Schneider, “Progress on Developing an Effective Below‐the‐Knee Drug‐Coated Balloon,” Reviews in Cardiovascular Medicine 22, no. 3 (2021): 585.
L. Garcia, M. R. Jaff, C. Metzger, et al., “Wire‐interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve‐Month Results of the SUPERB Trial,” Circulation: Cardiovascular Interventions 8, no. 5 (2015): e000937.
L. R. León, R. S. Dieter, C. L. Gadd, et al., “Preliminary Results of the Initial United States Experience With the Supera Woven Nitinol Stent in the Popliteal Artery,” Journal of Vascular Surgery 57, no. 4 (2013): 1014–1022.
J. Trentmann, N. Charalambous, M. Djawanscher, J. P. Schäfer, and T. Jahnke, “Safety and Efficacy of Directional Atherectomy for the Treatment of In‐Stent Restenosis of the Femoropopliteal Artery,” Journal of Cardiovascular Surgery 51, no. 4 (2010): 551–560.
E. J. Dippel, P. Makam, R. Kovach, et al., “Randomized Controlled Study of Excimer Laser Atherectomy for Treatment of Femoropopliteal In‐Stent Restenosis: Initial Results From the EXCITE ISR Trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In‐Stent Restenosis),” Journal of the American College of Cardiology: Cardiovascular Interventions 8, no. 1 (2015): 92–101.
O. Iida, Y. Soga, K. Urasawa, et al., “Drug‐Coated Balloon versus Uncoated Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Artery: 2‐Year Results of the MDT‐2113 SFA Japan Randomized Trial,” Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiovascular Angiography and Interventions 93, no. 4 (2019): 664–672.
J. Guo, L. Guo, S. Cui, et al., “A Retrospective Comparative Study of Twelve‐Month Clinical Outcomes for Drug‐Coating Balloon Angioplasty and Stent Implantation in Treating Patients With Popliteal Obstructive Lesions,” Cardiovascular and Interventional Radiology 44, no. 3 (2021): 361–367.
J. P. Goltz, C. O. Ritter, R. Kellersmann, D. Klein, D. Hahn, and R. Kickuth, “Endovascular Treatment of Popliteal Artery Segments p1 and p2 in Patients With Critical Limb Ischemia: Initial Experience Using a Helical Nitinol Stent With Increased Radial Force,” Journal of Endovascular Therapy 19, no. 3 (2012): 450–456.
C. Caradu, E. Lakhlifi, E. C. Colacchio, et al., “Systematic Review and Updated Meta‐Analysis of the Use of Drug‐Coated Balloon Angioplasty versus Plain Old Balloon Angioplasty for Femoropopliteal Arterial Disease,” Journal of Vascular Surgery 70, no. 3 (2019): 981–995. e10.
S. Salamaga, H. Stępak, M. Żołyński, et al., “Three‐Year Real‐World Outcomes of Interwoven Nitinol Supera Stent Implantation in Long and Complex Femoropopliteal Lesions,” Journal of Clinical Medicine 12, no. 14 (2023): 4869.
A. Sauguet, R. Philippart, and B. Honton, “Directional Atherectomy With Antirestenotic Therapy for the Treatment of No‐Stenting Zones,” Journal of Cardiovascular Surgery 60, no. 2 (2019): 198–204.
N. Troisi, A. Saratzis, E. Katsogridakis, et al., “Different Endovascular Modalities of Treatment for Isolated Atherosclerotic Popliteal Artery Lesions (EMO‐POP) Registry,” Journal of Vascular Surgery 77, no. 1 (2023): 231–240. e4.
D. I. Axel, W. Kunert, C. Göggelmann, et al., “Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery,” Circulation 96, no. 2 (1997): 636–645.
A. Schmidt, M. Piorkowski, M. Werner, et al., “First Experience With Drug‐Eluting Balloons in Infrapopliteal Arteries: Restenosis Rate and Clinical Outcome,” Journal of the American College of Cardiology 58, no. 11 (2011): 1105–1109.
E. C. Bair, B. C. McCarver, N. T. Cooper, et al., “The Use of Paclitaxel‐Coated Devices in the Treatment of Peripheral Arterial Disease is Not Associated With Increased Mortality or Amputations,” Annals of Vascular Surgery 87 (2022): 64–70.
Z. Chen, W. Guo, W. Jiang, et al., “IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug‐Coated Balloon in a Chinese Patient Population,” Journal of Endovascular Therapy: Official Journal of the International Society of Endovascular Specialists 26, no. 4 (2019): 471–478.
M. R. Jaff, K. Rosenfield, D. Scheinert, et al., “Drug‐Coated Balloons to Improve Femoropopliteal Artery Patency: Rationale and Design of the LEVANT 2 Trial,” American Heart Journal 169, no. 4 (2015): 479–485.
T. Dohi, A. Schmidt, D. Scheinert, et al., “Drug‐Coated Balloon Angioplasty in Atherosclerosis Patients With Popliteal Artery Involvement,” Journal of Endovascular Therapy: Official Journal of the International Society of Endovascular Specialists 25, no. 5 (2018): 581–587.
K. Stavroulakis, A. Schwindt, G. Torsello, et al., “Directional Atherectomy With Antirestenotic Therapy vs Drug‐Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions,” Journal of Endovascular Therapy: Official Journal of the International Society of Endovascular Specialists 24, no. 2 (2017): 181–188.
L. A. Garcia, M. R. Jaff, K. J. Rocha‐Singh, et al., “A Comparison of Clinical Outcomes for Diabetic and Nondiabetic Patients Following Directional Atherectomy in the DEFINITIVE LE Claudicant Cohort,” Journal of Endovascular Therapy: Official Journal of the International Society of Endovascular Specialists 22, no. 5 (2015): 701–711.
A. Rastan, J. F. McKinsey, L. A. Garcia, et al., “One‐Year Outcomes Following Directional Atherectomy of Popliteal Artery Lesions: Subgroup Analysis of the Prospective, Multicenter DEFINITIVE LE Trial,” Journal of Endovascular Therapy 25, no. 1 (2018): 100–108.
D. Pan, J. Guo, Z. Su, et al., “Safety and Efficacy of Excimer Laser Atherectomy Combined With a Drug‐Coated Balloon in De Novo Femoral Popliteal Artery Disease: A Retrospective Study,” Annals of Vascular Surgery 99 (2023): 26–32.
A. K. Krawisz, A. Raja, W. S. Jones, et al., “Long‐Term Outcomes of Peripheral Atherectomy for Femoropopliteal Endovascular Interventions,” EuroIntervention: Journal of the European Collaborative Work Group on Interventional Cardiology of the European Society of Cardiology 18, no. 16 (2023): e1378–e1387.
Y. Zhou, S. Lin, Z. Zhang, et al., “A Network Meta‐Analysis of Randomized Controlled Trials Comparing Treatment Modalities for Infrapopliteal Lesions in Critical Limb Ischemia,” Annals of Vascular Surgery 60 (2019): 424–434.